IRIS
VITALE, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.337
EU - Europa 6.938
AS - Asia 1.061
AF - Africa 34
SA - Sud America 19
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 15.405
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.328
GB - Regno Unito 2.564
IT - Italia 1.058
IE - Irlanda 982
CN - Cina 641
UA - Ucraina 578
SE - Svezia 524
RU - Federazione Russa 378
DE - Germania 270
FR - Francia 266
SG - Singapore 222
FI - Finlandia 184
VN - Vietnam 74
TR - Turchia 33
BE - Belgio 27
CZ - Repubblica Ceca 23
IN - India 23
CI - Costa d'Avorio 22
PL - Polonia 21
NL - Olanda 18
PK - Pakistan 18
ES - Italia 12
AU - Australia 9
BR - Brasile 9
JP - Giappone 9
IR - Iran 8
CA - Canada 7
HK - Hong Kong 6
EU - Europa 5
GR - Grecia 5
MA - Marocco 5
PT - Portogallo 4
SA - Arabia Saudita 4
AR - Argentina 3
BD - Bangladesh 3
EG - Egitto 3
HU - Ungheria 3
MY - Malesia 3
PE - Perù 3
RO - Romania 3
AL - Albania 2
BY - Bielorussia 2
CH - Svizzera 2
EC - Ecuador 2
ET - Etiopia 2
IL - Israele 2
KE - Kenya 2
KR - Corea 2
KZ - Kazakistan 2
LT - Lituania 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
ID - Indonesia 1
IQ - Iraq 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
TH - Thailandia 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
Totale 15.405
Salva come PNG Salva come JPEG
Città #
Southend 2.456
Fairfield 1.212
Dublin 968
Ashburn 645
Woodbridge 565
Jacksonville 473
Wilmington 468
Chandler 463
Seattle 461
Houston 445
Cambridge 420
Siena 343
Ann Arbor 326
Menlo Park 319
Princeton 233
Singapore 156
Nanjing 151
Beijing 133
New York 131
Helsinki 102
San Mateo 86
Dong Ket 73
Dearborn 72
Milan 72
San Diego 72
Boardman 64
Nanchang 58
Rome 43
Moscow 42
Shenyang 41
Düsseldorf 35
Shanghai 29
Tianjin 28
Florence 27
Jiaxing 27
Izmir 26
Hebei 25
Changsha 24
Washington 24
Brussels 23
Abidjan 22
Norwalk 21
Kraków 20
Bologna 19
Los Angeles 19
Olomouc 18
Jinan 17
Kunming 17
Munich 17
San Francisco 15
Santa Clara 15
London 14
Turin 14
Guangzhou 13
Redwood City 13
Frankfurt am Main 11
Padova 11
Saint Petersburg 11
Livorno 10
Málaga 10
Tappahannock 10
Cecina 9
Lancaster 9
Monza 9
Sutri 9
Changchun 8
Dallas 8
Hangzhou 8
Lahore 8
Lanzhou 8
Perugia 8
Taizhou 8
Zhengzhou 8
Cagliari 7
Falls Church 7
Palermo 7
Venezia 7
Asciano 6
Bergamo 6
Campi Bisenzio 6
Catania 6
Fort Worth 6
Genoa 6
Lucca 6
Naples 6
Salerno 6
Brindisi 5
Cardiff 5
Fremont 5
Ningbo 5
Paris 5
Pavia 5
Ravenna 5
Reggio Emilia 5
Seveso 5
São Paulo 5
Uzzano 5
Venice 5
Zanjan 5
Amsterdam 4
Totale 11.929
Salva come PNG Salva come JPEG
Nome #
VEXAS syndrome: a new paradigm for adult-onset monogenic autoinflammatory diseases 412
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 255
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 243
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 230
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 210
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 197
A Snapshot on the On-Label and Off-Label Use of the Interleukin-1 Inhibitors in Italy among Rheumatologists and Pediatric Rheumatologists: A Nationwide Multi-Center Retrospective Observational Study 196
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 196
Weekly oral alendronate in mevalonate kinase deficiency 189
A comprehensive comparison between pediatric and adult patients with periodic fever, aphthous stomatitis, pharyngitis, and cervical adenopathy (PFAPA) syndrome 188
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 184
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 179
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 176
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 174
Biological treatments: new weapons in the management of monogenic autoinflammatory disorders 173
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 173
Caveats and truths in genetic, clinical, autoimmune and autoinflammatory issues in Blau syndrome and early onset sarcoidosis 169
Systemic Steroid Sparing Effect of Intravitreal Dexamethasone Implant in Chronic Noninfectious Uveitic Macular Edema 169
Working the endless puzzle of hereditary autoinflammatory disorders. 168
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 168
Certolizumab Pegol treatment in Behcet’s disease with different organ involvement: a multicenter retrospective observational study 165
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 161
Switch from infliximab to infliximab biosimilar: efficacy and safety in a cohort of patients with different rheumatic diseases: Response to: Nikiphorou E, Kautiainen H, Hannonen P, et al. Clinical effectiveness of CT-P13 (Infliximab biosimilar) used as a switch from Remicade (infliximab) in patients with established rheumatic disease. Report of clinical experience based on prospective observational data. Expert Opin Biol Ther. 2015;15:1677–1683 160
Efficacy and Safety of Adalimumab in Behçet’s disease related uveitis: a multicenter retrospective observational study 158
Challenges and new horizons in the periodic fever, aphthous stomatitis, pharyngitis and adenitis (PFAPA) syndrome 157
Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease 157
Adalimumab effectiveness in Behçet’s disease: short and long-term data from a multicenter retrospective observational study 157
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 152
null 150
Immunometabolic biomarkers of inflammation in Behçet's disease: Relationship with epidemiological profile, disease activity and therapeutic regimes 147
Correlation between serum amyloid-A and serum levels of proinflammatory cytokines in patients with Behçet's disease 146
The hereditary autoinflammatory disorders uncovered 145
Diagnostic criteria for adult-onset periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome 142
The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature 142
Interleukin (IL)-1 inhibition with anakinra and canakinumab in Behçet’s disease-related uveitis: a multicenter retrospective observational study 141
Coexistence of axial spondyloarthritis and thromboangiitis obliterans in a young woman 139
Clinical and biochemical landmarks in systemic autoinflammatory diseases 138
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 138
The common NOD2/CARD15 variant P268S in patients with non-infectious uveitis: a cohort study 137
Childhood versus adulthood-onset autoinflammatory disorders: myths and truths intertwined 135
Interleukin-1 as a common denominator from autoinflammatory to autoimmune disorders: premises, perils, and perspectives 134
Critical regulation of Th17 cell differentiation by serum amyloid-A signalling in Behcet's disease 133
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 132
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 132
Treating juvenile idiopathic arthritis (JIA)-related uveitis beyond TNF-α inhibition: a narrative review 132
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 132
Adalimumab effectively controls both anterior and posterior noninfectious uveitis associated with systemic inflammatory diseases: focus on Behçet’s syndrome 132
null 131
The role of the F402L allele in the NLRP12-autoinflammatory disorder. Reply to: F402L variant in NLRP12 in subjects with undiagnosed periodic fevers and in healthy controls 131
Long-term efficacy and safety of the interleukin-1 inhibitors anakinra and canakinumab in refractory Behçet disease uveitis and concomitant bladder papillary carcinoma 128
Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives 128
The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: Clinical manifestations and long-term follow-up 127
Idiopathic inflammatory myopathies: an update on classification and treatment with special focus on juvenile forms 127
Adalimumab-Based Treatment Versus Disease-Modifying Antirheumatic Drugs for Venous Thrombosis in Behçet's Syndrome: A Retrospective Study of Seventy Patients With Vascular Involvement 127
Diagnosis and classification of relapsing polychondritis 126
Long-term efficacy and safety of anakinra in a patient with Behçet's disease and concomitant tuberculosis infection 126
Monogenic autoinflammatory syndromes: state of the art on genetic, clinical, and therapeutic issues 125
A case of resistant adult-onset periodic fever, aphthous stomatitis, pharyngitis and cervical adenitis (PFAPA) syndrome responsive to anakinra. 124
Serum amyloid-A in Behçet's disease 124
Key facts and hot spots on tumor necrosis factor receptor-associated periodic syndrome 123
null 121
Circulating intercellular adhesion molecule 1 (sICAM-1) in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 120
null 119
null 118
Anakinra long-term efficacy and safety in the management of Schnitzler's syndrome and latent tuberculosis infection 118
Long-term safety of anti-TNF agents on the liver of patients with spondyloarthritis and potential occult hepatitis B viral infection: An observational multicentre study 118
Inhibition of Interleukin-1 by Canakinumab as a Successful Mono-Drug Strategy for the Treatment of Refractory Behçet's Disease: A Case Series 117
null 117
Paradoxical mucocutaneous flare in a case of Behçet's disease treated with tocilizumab 117
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 117
null 116
null 115
null 115
Clues to detect tumor necrosis factor receptor-associated periodic syndrome (TRAPS) among patients with idiopathic recurrent acute pericarditis: results of a multicentre study 115
null 113
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 113
null 112
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 109
null 107
null 107
Proinflammatory Cytokines and Antiskin Autoantibodies in Patients With Inherited Epidermolysis Bullosa 104
null 104
Evolving Frontiers in the Treatment of Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Syndrome 103
null 102
The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review 98
null 98
Diagnosis of PFAPA syndrome applied to a cohort of 17 adults with unexplained recurrent fevers 96
Adalimumab Accounts for Long-Term Control of Noninfectious Uveitis Also in the Absence of Concomitant DMARD Treatment: A Multicenter Retrospective Study 96
null 95
Rare NLRP12 variants associated with the NLRP12-autoinflammatory disorder phenotype: an Italian case series 95
null 94
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 92
Interleukin-1: Ariadne's Thread in Autoinflammatory and Autoimmune Disorders 90
Successful use of canakinumab in a patient with resistant Behçet's disease 89
Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases 89
Efficacy of anakinra in refractory Behçet's disease sacroiliitis 86
Expanding spectrum of TNFRSF1A gene mutations among patients with idiopathic recurrent acute pericarditis 85
Long-term clinical course of patients carrying the Q703K mutation in the NLRP3 gene: a case series 83
Autoinflammatory diseases 83
Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report 80
Totale 13.756
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.039
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.039
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.596 0 0 174 431 166 276 260 373 310 317 103 186
2020/20212.673 251 260 108 220 190 353 105 396 119 262 154 255
2021/20221.917 183 234 118 134 99 35 82 64 142 231 205 390
2022/20231.801 116 151 244 220 168 341 54 140 209 24 78 56
2023/20241.952 78 47 173 109 96 517 550 81 17 68 65 151
2024/2025988 263 221 504 0 0 0 0 0 0 0 0 0
Totale 15.944